$39.50
At close: Mar 10, 11:05 AM EDT
Comments
Loading...
Xvivo Perfusion Analyst Ratings and Price Targets | OTC:XVIPF | Benzinga
Xvivo Perfusion Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Xvivo Perfusion Corp from these most-recent analyst ratings.
Analyst Ratings for Xvivo Perfusion
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Xvivo Perfusion (XVIPF) stock?
There is no price target for Xvivo Perfusion
What is the most recent analyst rating for Xvivo Perfusion (XVIPF)?
There is no analyst for Xvivo Perfusion
When was the last upgrade for Xvivo Perfusion (XVIPF)?
There is no last upgrade for Xvivo Perfusion
When was the last downgrade for Xvivo Perfusion (XVIPF)?
There is no last downgrade for Xvivo Perfusion.
When is the next analyst rating going to be posted or updated for Xvivo Perfusion (XVIPF)?
There is no next analyst rating for Xvivo Perfusion.
Is the Analyst Rating Xvivo Perfusion (XVIPF) correct?
There is no next analyst rating for Xvivo Perfusion.
Browse analyst ratings and price targets on all stocks.